Skip to content

Collaborative care program for patients with treatment resistant schizophrenia.

Collaborative care program for patients with treatment resistant schizophrenia. - Collaborative care for patients with treatment resistant schizophrenia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52870
Enrollment
3
Registered
2019-08-23
Start date
2020-11-22
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

long-lasting psychosis treatment resistant schizophrenia

Interventions

Collaborative care program for patïents with treatment resistant schizophrenia

Sponsors

Reinier van Arkelgroep (Den Bosch)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The intervention study includes patients over 18 years of age with treatment resistant schizophrenia and who receive treatment from participating EPIT and FACT (these patients were identified in the cross-sectional study). These patients do not use clozapine at the time of inclusion.

Exclusion criteria

Exclusion criteria: - Patients who not master the Dutch language to complete in questionnaires and giving an interview. - Patients without informed consent.

Design outcomes

Primary

MeasureTime frame
Improving social functioning

Secondary

MeasureTime frame
Reduce psychotic symptoms Improve quality of life Improve recovery Improve shared decision making Enhance self management Reduce and/or early identifcation of somatic co-morbidit

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)